Puma Biotechnology Inc (NASDAQ: PBYI): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that N/A.

Stocks Info

PBYI belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Puma Biotechnology Inc is $145.67M. A total of 0.57 million shares were traded on the day, compared to an average of 383.39K shares.

In the most recent transaction, MILLER MICHAEL PATRICK sold 23,358 shares of PBYI for 3.49 per share on Aug 12 ’24. After the transaction, the Director now owns 47,000 company shares. In a previous transaction on Aug 12 ’24, MILLER MICHAEL PATRICK bought 23,358 shares at 3.76 per share.

Among the insiders who sold shares, NOUGUES MAXIMO F disposed of 4,156 shares on Jul 17 ’24 at a per-share price of $3.70. This resulted in the Chief Financial Officer holding 162,522 shares of PBYI after the transaction. In another insider transaction, Ludwig Jeffrey Jerome sold 2,598 shares at $3.70 per share on Jul 17 ’24. Company shares held by the Chief Commercial Officer now total 118,388.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PBYI has a high of $7.73 and a low of $2.22.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PBYI’s latest balance sheet shows that the firm has $82.11M in Cash & Short Term Investments as of fiscal 2021. There were $116.64M in debt and $109.59M in liabilities at the time. Its Book Value Per Share was $1.45, while its Total Shareholder’s Equity was $-2.45M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PBYI is Buy with a score of 3.00.

Most Popular

Related Posts